Superficial bladder cancer T1G3: the choice of treatment.
Borkowski
A
A
Department of Urology, Medical University, Warsaw, Poland. urolwa@warman.com.pl
D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001706:Biopsy / Q000379:methods; D018450:Disease Progression; D006801:Humans; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging / Q000379:methods; D012086:Reoperation; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*
D000970:Antineoplastic Agents